321 related articles for article (PubMed ID: 29683546)
1. Kappa free light chains in cerebrospinal fluid to identify patients with oligoclonal bands.
Süße M; Hannich M; Petersmann A; Zylla S; Pietzner M; Nauck M; Dressel A
Eur J Neurol; 2018 Sep; 25(9):1134-1139. PubMed ID: 29683546
[TBL] [Abstract][Full Text] [Related]
2. CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort.
Senel M; Mojib-Yezdani F; Braisch U; Bachhuber F; Lewerenz J; Ludolph AC; Otto M; Tumani H
Front Immunol; 2019; 10():641. PubMed ID: 30984199
[No Abstract] [Full Text] [Related]
3. Application of κ free light chains in cerebrospinal fluid as a biomarker in multiple sclerosis diagnosis: development of a diagnosis algorithm.
Valencia-Vera E; Martinez-Escribano Garcia-Ripoll A; Enguix A; Abalos-Garcia C; Segovia-Cuevas MJ
Clin Chem Lab Med; 2018 Mar; 56(4):609-613. PubMed ID: 29087953
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal immunoglobulin synthesis: The potential value of an adjunct test.
Emersic A; Anadolli V; Krsnik M; Rot U
Clin Chim Acta; 2019 Feb; 489():109-116. PubMed ID: 30529605
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid kappa and lambda free light chains in oligoclonal band-negative patients with suspected multiple sclerosis.
Ferraro D; Trovati A; Bedin R; Natali P; Franciotta D; Santangelo M; Camera V; Vitetta F; Varani M; Trenti T; Gastaldi M; De Biasi S; Nasi M; Pinti M; Meletti S; Sola P
Eur J Neurol; 2020 Mar; 27(3):461-467. PubMed ID: 31710409
[TBL] [Abstract][Full Text] [Related]
6. Kappa Free Light Chains in Cerebrospinal Fluid of Patients with Identified Oligoclonal Immunoglobulin G.
Vasilj M; Klarić M; Vrkić N; Mikulić I; Boras MM; Jelić-Knezović N; Šoljić V
Psychiatr Danub; 2017 May; 29(Suppl 2):124-128. PubMed ID: 28492219
[TBL] [Abstract][Full Text] [Related]
7. Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study.
Presslauer S; Milosavljevic D; Huebl W; Aboulenein-Djamshidian F; Krugluger W; Deisenhammer F; Senel M; Tumani H; Hegen H
Mult Scler; 2016 Apr; 22(4):502-10. PubMed ID: 26199348
[TBL] [Abstract][Full Text] [Related]
8. Free Kappa light chains in neuroinflammatory disorders: Complement rather than substitute?
Bayart JL; Muls N; van Pesch V
Acta Neurol Scand; 2018 Oct; 138(4):352-358. PubMed ID: 29900542
[TBL] [Abstract][Full Text] [Related]
9. Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.
Leurs CE; Twaalfhoven H; Lissenberg-Witte BI; van Pesch V; Dujmovic I; Drulovic J; Castellazzi M; Bellini T; Pugliatti M; Kuhle J; Villar LM; Alvarez-Cermeño JC; Alvarez-Lafuente R; Hegen H; Deisenhammer F; Walchhofer LM; Thouvenot E; Comabella M; Montalban X; Vécsei L; Rajda C; Galimberti D; Scarpini E; Altintas A; Rejdak K; Frederiksen JL; Pihl-Jensen G; Jensen P; Khalil M; Voortman MM; Fazekas F; Saiz A; La Puma D; Vercammen M; Vanopdenbosch L; Uitdehaag B; Killestein J; Bridel C; Teunissen C
Mult Scler; 2020 Jul; 26(8):912-923. PubMed ID: 31066634
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of intrathecal kappa free light chains compared with OCBs in MS.
Duell F; Evertsson B; Al Nimer F; Sandin Å; Olsson D; Olsson T; Khademi M; Hietala MA; Piehl F; Hansson M
Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32527760
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis.
Presslauer S; Milosavljevic D; Brücke T; Bayer P; Hübl W
J Neurol; 2008 Oct; 255(10):1508-14. PubMed ID: 18685917
[TBL] [Abstract][Full Text] [Related]
12. Determination of κFLC and κ Index in cerebrospinal fluid: a valid alternative to assess intrathecal immunoglobulin synthesis.
Duranti F; Pieri M; Centonze D; Buttari F; Bernardini S; Dessi M
J Neuroimmunol; 2013 Oct; 263(1-2):116-20. PubMed ID: 23916392
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of CSF kappa free light chains for the diagnosis of multiple sclerosis (MS): a comparison with oligoclonal bands (OCB) detection via isoelectric focusing (IEF) coupled with immunoblotting.
Abid MA; Ahmed S; Muneer S; Khan S; de Oliveira MHS; Kausar R; Siddiqui I
J Clin Pathol; 2023 May; 76(5):353-356. PubMed ID: 36130824
[TBL] [Abstract][Full Text] [Related]
14. Free light chains as a reliable biomarker of intrathecal synthesis in the diagnosis of CNS inflammatory diseases.
Michetti L; Maffina F; Ravasio R; Barcella V; Radaelli M; Chiudinelli L; Sessa M; Alessio MG
J Neuroimmunol; 2023 Jun; 379():578091. PubMed ID: 37210840
[TBL] [Abstract][Full Text] [Related]
15. The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis.
Schwenkenbecher P; Konen FF; Wurster U; Jendretzky KF; Gingele S; Sühs KW; Pul R; Witte T; Stangel M; Skripuletz T
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30501024
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis.
Hegen H; Walde J; Berek K; Arrambide G; Gnanapavan S; Kaplan B; Khalil M; Saadeh R; Teunissen C; Tumani H; Villar LM; Willrich MAV; Zetterberg H; Deisenhammer F
Mult Scler; 2023 Feb; 29(2):169-181. PubMed ID: 36453167
[TBL] [Abstract][Full Text] [Related]
17. CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexes.
Gurtner KM; Shosha E; Bryant SC; Andreguetto BD; Murray DL; Pittock SJ; Willrich MAV
Clin Chem Lab Med; 2018 Jun; 56(7):1071-1080. PubMed ID: 29455184
[TBL] [Abstract][Full Text] [Related]
18. High sensitivity and specificity of elevated cerebrospinal fluid kappa free light chains in suspected multiple sclerosis.
Hassan-Smith G; Durant L; Tsentemeidou A; Assi LK; Faint JM; Kalra S; Douglas MR; Curnow SJ
J Neuroimmunol; 2014 Nov; 276(1-2):175-9. PubMed ID: 25146968
[TBL] [Abstract][Full Text] [Related]
19. Kappa free light chains: Diagnostic performance in multiple sclerosis and utility in a clinical laboratory.
Alves Martins D; Lopes J; Martins da Silva A; Morais CI; Vasconcelos J; Lima I; Carneiro C; Neves E
Clin Chim Acta; 2022 Mar; 528():56-64. PubMed ID: 35092724
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid immunoglobulin kappa light chain in clinically isolated syndrome and multiple sclerosis.
Senel M; Tumani H; Lauda F; Presslauer S; Mojib-Yezdani R; Otto M; Brettschneider J
PLoS One; 2014; 9(4):e88680. PubMed ID: 24695382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
